Logo for Algernon Pharmaceuticals Inc.
AGN

Algernon Pharmaceuticals Inc.

Titres Associés:
Statut
Actif
Émis et en Circulation21,940,779
Réservé pour Émission14,087,036
Devise
CSE Indice

À propos

Algernon Pharmaceuticals Inc.

Date d'inscription
01 février 2016

Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.